EIG
Evercore ISI Group Latest Price Targets & Analyst Ratings
# | Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|---|
801 |
801
Alphabet (Google) Class A
GOOGL
$2.84T
|
KR
Kevin Rippey
| $235 | $120 |
49%
downside
| Outperform | 4 years ago |
|
802 |
802
Cullinan Oncology
CGEM
$413M
|
JS
Josh Schimmer
| $6.99 | $55 |
687%
upside
| Outperform | 4 years ago |
|
803 |
803
TETRA Technologies
TTI
$625M
|
JW
James West
| $4.69 | $3 |
36%
downside
| Outperform | 4 years ago |
|
804 |
804
Meta Platforms (Facebook)
META
$1.89T
|
KR
Kevin Rippey
| $752.45 | $360 |
52%
downside
| Outperform | 4 years ago |
|
805 |
805
Liberty Energy
LBRT
$1.7B
|
JW
James West
| $10.48 | $15 |
43%
upside
| Outperform | 4 years ago |
|
806 |
XYZ
806
Block, Inc.
XYZ
$45.7B
|
RK
Rayna Kumar
| $74.94 | $304 |
306%
upside
| Outperform | 4 years ago |
|
807 |
807
National Storage Affiliates Trust
NSA
$2.56B
| $33.30 | $42 |
26%
upside
| Outperform | 4 years ago |
|
|
808 |
808
Aon
AON
$79.9B
| $370.54 | $231 |
38%
downside
| In-Line | 4 years ago |
|
|
809 |
809
Arthur J. Gallagher & Co
AJG
$76.7B
| $299.18 | $145 |
52%
downside
| Outperform | 4 years ago |
|
|
810 |
810
Theravance Biopharma
TBPH
$703M
|
LB
Liisa Bayko
| $13.95 | $30 |
115%
upside
| Outperform | 4 years ago |
|
811 |
811
Altimmune
ALT
$334M
| $3.78 | $25 |
561%
upside
| Outperform | 4 years ago |
|
|
812 |
812
Root
ROOT
$1.43B
| $92.64 | $432 |
366%
upside
| In-Line | 4 years ago |
|
|
813 |
813
Electronic Arts
EA
$42.2B
|
BB
Benjamin Black
| $168.62 | $135 |
20%
downside
| In-Line | 4 years ago |
|
814 |
814
New York Times
NYT
$9.6B
|
JB
John Belton
| $58.99 | $48 |
19%
downside
| Outperform | 4 years ago |
|
815 |
815
Analog Devices
ADI
$122B
| $247.07 | $160 |
35%
downside
| Outperform | 4 years ago |
|
|
816 |
816
Kroger
KR
$44.8B
|
MM
Michael Marchallinger
| $67.75 | $36 |
47%
downside
| In-Line | 4 years ago |
|
817 |
817
Eastman Chemical
EMN
$7.93B
|
SR
Stephen Richardson
| $69.06 | $91 |
32%
upside
| In-Line | 5 years ago |
|
818 |
818
Inhibrx
INBX
$408M
| $28.18 | $30 |
6%
upside
| Outperform | 5 years ago |
|
|
819 |
819
DraftKings
DKNG
$23.1B
|
KR
Kevin Rippey
| $46.56 | $60 |
29%
upside
| Outperform | 5 years ago |
|
820 |
820
FedEx
FDX
$53.7B
| $227.72 | $300 |
32%
upside
| Outperform | 5 years ago |
|
|
821 |
821
Aptiv
APTV
$17.5B
| $80.44 | $110 |
37%
upside
| Outperform | 5 years ago |
|
|
822 |
822
Ford
F
$46.7B
| $11.74 | $8 |
32%
downside
| In-Line | 5 years ago |
|
|
823 |
823
FirstEnergy
FE
$25.1B
| $43.48 | $41 |
6%
downside
| In-Line | 5 years ago |
|
|
824 |
824
AllianceBernstein
AB
$4.29B
| $38.82 | $30 |
23%
downside
| Outperform | 5 years ago |
|
|
825 |
825
Warner Music
WMG
$17B
|
JB
John Belton
| $32.69 | $36 |
10%
upside
| Outperform | 5 years ago |
|